10x Genomics(US:TXG) Prnewswire·2025-02-23 16:30Core Insights - 10x Genomics announced new product innovations to enhance its leadership in single cell and spatial biology, aiming to support high-performance research at scale [1][2] - The company revealed a comprehensive product roadmap for its Visium and Xenium portfolios, focusing on advancements in spatial biology technology [1][3] Single Cell Innovations - The upcoming plate-based workflows for Chromium GEM-X Flex will allow researchers to process over 700 samples in a single run, recovering approximately 1 million cells from a single lane and 8 million cells per chip [3][5] - 10x Cloud Analysis for Large Studies will introduce batch analysis features for managing large datasets, enabling hundreds or thousands of analyses to run in parallel [3][5] - Recent innovations aim to democratize access to single cell analysis by providing high performance at low costs, including GEM-X Flex Gene Expression at one cent per cell and GEM-X Universal Multiplex for approximately $600 per sample [5][6] Spatial Biology Advancements - The Visium HD product launched in 2024 significantly increased resolution and is now compatible with various tissue types, enhancing sensitivity and sequencing efficiency [7][9] - Planned additions to the Visium HD platform include the Visium HD 3' assay for whole transcriptome spatial profiling and Visium HD Cell Segmentation for improved spatial transcriptomics data resolution [9][10] - The Xenium RNA+Protein Multiomics will enable simultaneous detection of RNA and proteins, enhancing multiomic insights into cellular functions [7][9] Company Events and Engagement - 10x Genomics will host a workshop at the AGBT meeting to share the latest developments and data across its platforms, with a live-stream option for remote participants [2][8] - The company is actively showcasing its technologies through scientific presentations and events at AGBT, emphasizing its role in driving biological discovery [8][11]